Jason Portnof, DMD
Oral & Maxillofacial Surgery · Boca Raton, FLNPI 1760613426
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (28.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Synthes GmbH at 40.1% of the total. Among oral & maxillofacial surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $149.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$4K
- Axogen$1K
- Zimmer Biomet$1K
- Pacira Pharmaceuticals Incorporated$1K
- Straumann USA LLC$662
- Innovation Technologies Inc$159
- plus $377 from 10 others
What the payments were for
- Consulting fees$1,25014%
- Speaking & faculty fees$2,52729%
- Travel & lodging$1,95422%
- Food & beverage$1,80020%
- Education$1,16713%
- Gifts$901%
- Entertainment$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 8 | $3,535 |
| Axogen | 5 | $1,495 |
| Zimmer Biomet | 17 | $1,303 |
| Pacira Pharmaceuticals Incorporated | 5 | $1,292 |
| Straumann USA LLC | 12 | $662 |
| Innovation Technologies Inc | 1 | $159 |
| Covidien LP | 1 | $103 |
| Nobel Biocare USA | 1 | $90 |
| Johnson & Johnson | 1 | $39 |
| Bioventus LLC | 1 | $29 |
| Dentsply Sirona Inc | 1 | $27 |
| Kls-martin L.p. | 2 | $24 |
| Eagle Pharmaceuticals, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Colgate Oral Pharmaceuticals, Inc. | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$2,959
- AXOGUARD HA+ NERVE PROTECTOR$1,479
- AxoGuard Nerve Cap$1,479
- EXPAREL$1,000
- All Osseotite Implants$500
- Irrisept$159
- Situate$103
How this compares
$8,822 in reported general payments places this provider in the 90th percentile of 498 oral & maxillofacial surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 182 | $756 |
| Amoxicillin | 132 | $421 |
| Ibuprofen | 99 | $297 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $228 |
| Clindamycin Hcl | 28 | $212 |
| Methylprednisolone | 22 | $127 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $107 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Boca Raton
- Michael PikosPalm Harbor$3M
- Ramon RuizOrlando$846K
- Curtis SchalitDaytona Beach$333K
- Rui FernandesJacksonville$107K
- Tyler HolleyOrlando$55K
- Shaun YoungNew Port Richey$46K
- Eduardo NicolaievskyMiami Beach$45K
- Craig MischSarasota$43K
- Jose MonteroMiami$42K
- Ramzey TursunMiami$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.